Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Hazal Ceren Manazoğlu, Murat Kürtüncü

DOI: 10.55697/tnd.2025.500

Issue: 2025, Volume 31 - Issue 3
7752 6065

Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study

Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2025.494

Issue: 2025, Volume 31 - Issue 3
1342 722

Monocytes and systemic inflammation in Guillain-Barré syndrome: Subtypes and relationship with prognosis

Memet Aslanyavrusu, Fahrettin Ege, Gülhan Sarıçam

DOI: 10.55697/tnd.2025.508

Issue: 2025, Volume 31 - Issue 3
1024 725

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
881 666

Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis

Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi

DOI: 10.55697/tnd.2025.323

Issue: 2025, Volume 31 - Issue 4
194 255

Audiovestibular findings according to the subtypes of multiple sclerosis

Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz

DOI: 10.55697/tnd.2025.442

Issue: 2025, Volume 31 - Issue 4
180 296

Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning

Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş

DOI: 10.55697/tnd.2025.511

Issue: 2025, Volume 31 - Issue 4
239 267

Antiquity, past, present, and future of in vivo diagnosis of Alzheimer’s disease

Hakan Gürvit

DOI: 10.55697/tnd.2025.533

Issue: 2025, Volume 31 - Issue 4
232 958